SHC earnings date and last-quarter result: last quarter beat, P/E 42.04. Updated 2026-07-23.
Sotera Health (SHC) Research Hub
Sotera Health (SHC) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 18.39 USD (+1.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 42.04, market cap 4.94B. This hub links to the full technical, earnings and options research available for SHC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 18.39 USD (+1.60%) |
| 52-week range | 15.39 USD – 19.79 USD |
| Trend regime | Range |
| 14-day RSI | 52.2 (Neutral) |
| Trailing P/E | 42.04 |
| Market cap | 4.94B |
| Dividend yield | 0.00% |
Available research for SHC
Covered Call on SHC: how it works, illustrative setup around the real 18.39 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SHC: how it works, illustrative setup around the real 18.39 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SHC: how it works, illustrative setup around the real 18.39 USD price, max profit/loss, breakeven and when to use it. Educational.
SHC technical analysis: range, last 18.39 USD, RSI 52.2, 52w range 15.39 USD–19.79 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SHC in?
Sotera Health (SHC) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is SHC in an uptrend or downtrend?
As of 2026-10-26, SHC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SHC's trailing P/E ratio?
SHC's trailing P/E is 42.04, with a market cap of 4.94B. See the earnings research page for full valuation detail.